BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38486819)

  • 1. Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease.
    Johansen S; Langkjær S; Rasmussen DN; Israelsen M; Torp N; Lindvig K; Kjærgaard M; Hansen JK; Hansen CD; Thorhauge K; Andersen P; Detlefsen S; Juel HB; Justesen US; Hansen T; Krag A; Thiele M; ;
    JHEP Rep; 2024 Apr; 6(4):101016. PubMed ID: 38486819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
    Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
    J Hepatol; 2024 Feb; ():. PubMed ID: 38428644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
    Israelsen M; Torp N; Johansen S; Hansen CD; Hansen ED; Thorhauge K; Hansen JK; Villesen I; Bech K; Wernberg C; Andersen P; Lindvig KP; Tsochatzis EA; Thiele M; Rinella ME; Krag A;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):218-228. PubMed ID: 38218202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
    Lackner C; Spindelboeck W; Haybaeck J; Douschan P; Rainer F; Terracciano L; Haas J; Berghold A; Bataller R; Stauber RE
    J Hepatol; 2017 Mar; 66(3):610-618. PubMed ID: 27894795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
    Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
    JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen proportionate area predicts clinical outcomes in patients with alcohol-related liver disease.
    Israelsen M; Guerrero Misas M; Koutsoumourakis A; Huang Y; Thiele M; Hall A; Rasmussen D; Covelli C; Buzzetti E; Prat LI; Roccarina D; Detlefsen S; Luong TV; Quaglia A; Krag A; Jeffrey G; Pinzani M; Tsochatzis EA
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1728-1739. PubMed ID: 33044010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease.
    Hagström H; Thiele M; Simon TG; Sharma R; Röckert Tjernberg A; Roelstraete B; Söderling J; Ludvigsson JF
    United European Gastroenterol J; 2022 Mar; 10(2):198-211. PubMed ID: 35088575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease.
    Rasmussen DN; Thiele M; Johansen S; Kjærgaard M; Lindvig KP; Israelsen M; Antonsen S; Detlefsen S; Krag A; ;
    J Hepatol; 2021 Nov; 75(5):1017-1025. PubMed ID: 34118335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death.
    Smith AD; Zand KA; Florez E; Sirous R; Shlapak D; Souza F; Roda M; Bryan J; Vasanji A; Griswold M; Lirette ST
    Radiology; 2017 Jun; 283(3):711-722. PubMed ID: 27809664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease.
    Lackner C; Stauber RE; Davies S; Denk H; Dienes HP; Gnemmi V; Guido M; Miquel R; Paradis V; Schirmacher P; Terracciano L; Berghold A; Pregartner G; Binder L; Douschan P; Rainer F; Sygulla S; Jager M; Rautou PE; Bumbu A; Horhat A; Rusu I; Stefanescu H; Detlefsen S; Krag A; Thiele M; Cortez-Pinto H; Moreno C; Gouw ASH; Tiniakos DG
    J Hepatol; 2021 Oct; 75(4):810-819. PubMed ID: 34126105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
    Alkhouri N; Almomani A; Le P; Payne JY; Asaad I; Sakkal C; Vos M; Noureddin M; Kumar P
    BMC Gastroenterol; 2022 Jul; 22(1):366. PubMed ID: 35907827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis.
    Hofer BS; Simbrunner B; Hartl L; Jachs M; Bauer DJM; Balcar L; Paternostro R; Schwabl P; Semmler G; Scheiner B; Staettermayer AF; Trauner M; Mandorfer M; Reiberger T
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2308-2317.e7. PubMed ID: 36481475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications.
    Elshaarawy O; Mueller J; Guha IN; Chalmers J; Harris R; Krag A; Madsen BS; Stefanescu H; Farcau O; Ardelean A; Procopet B; Thiele M; Mueller S
    JHEP Rep; 2019 Aug; 1(2):99-106. PubMed ID: 32039357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
    Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Brujats A; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J;
    J Hepatol; 2021 Sep; 75(3):589-599. PubMed ID: 33905794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
    Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
    Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
    Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-dependent expression of fibrogenic markers in alcohol-related liver disease.
    Sørensen MD; Thiele M; Krag A; Daniels SJ; Leeming DJ; Karsdal M; Detlefsen S
    Pathol Res Pract; 2022 Mar; 231():153798. PubMed ID: 35180651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.